Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Sterile Injectable Manufacturing: SOP for Labeling of Dispensed Materials – V 2.0

Posted on By

Sterile Injectable Manufacturing: SOP for Labeling of Dispensed Materials – V 2.0

Standard Operating Procedure for Labeling of Dispensed Materials in Sterile Injectable Manufacturing


Department Sterile Injectable Manufacturing
SOP No. SOP/SIM/008/2025
Supersedes SOP/SIM/008/2022
Page No. Page 1 of 13
Issue Date 17/06/2025
Effective Date 19/06/2025
Review Date 17/06/2026

1. Purpose

To describe the procedure for proper labeling of raw materials after dispensing to ensure traceability, accurate identification, segregation, and regulatory compliance with GMP standards for sterile injectable manufacturing.

2.

Scope

This SOP is applicable to all dispensed raw materials (actives and excipients) at the sterile injectable manufacturing facility that are to be used in batch manufacturing.

3. Responsibilities

  • Warehouse Staff: Responsible for generating and affixing correct labels to dispensed materials.
  • QA Officer: Verifies label contents and correctness, signs off for approval.
  • Production Pharmacist: Ensures labels match BMR entries before use.

4. Accountability

The Head of Warehouse is accountable for ensuring that no dispensed material leaves the area without a correct and compliant label as per this SOP.

5. Procedure

5.1 Preparation for Labeling

  1. Use a printed template as per approved format for all labels to avoid manual errors.
  2. Labels must be pre-approved by QA and bear controlled document status.

5.2 Label Format Requirements

  1. Each label must contain the following information:
    • Material Name (as per BMR)
    • Material Code
    • Batch Number (Raw Material)
    • Quantity Dispensed (with units)
    • Date of Dispensing
    • Container Number (e.g., 1 of 3, 2 of 3)
    • Dispensed By (initials/signature)
  2. Use waterproof adhesive labels printed with clear and legible font (minimum size: 10 pt).

5.3 Labeling Execution

  1. Affix the label immediately after completion of each individual material weighing.
  2. Ensure the label is securely adhered to the container and is not covering any critical markings.
  3. In case of label damage or error, strike the label diagonally, attach a new one, and document the change.

5.4 QA Verification

  1. QA shall verify each label against the MRN and BMR before approving it for material release.
  2. Labels verified and signed by QA must not be altered without QA reapproval.

5.5 Label Storage and Control

  1. Unused printed labels must be accounted for and destroyed in presence of QA.
  2. Label issuance and destruction shall be documented in the Label Control Log (Annexure-3).

6. Abbreviations

  • SOP: Standard Operating Procedure
  • QA: Quality Assurance
  • BMR: Batch Manufacturing Record
  • MRN: Material Requisition Note

7. Documents

  1. Label Template Record – Annexure-1
  2. Labeling Verification Log – Annexure-2
  3. Label Control Log – Annexure-3

8. References

  • WHO GMP – Annex 6
  • ICH Q10 – Pharmaceutical Quality System
  • Schedule M – Good Manufacturing Practice (India)

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation Store Chemist QA Executive Head – Manufacturing
Department Warehouse Quality Assurance Sterile Injectable Manufacturing

11. Annexures

Annexure-1: Label Template Record

Field Example
Material Name Sodium Chloride
Batch No. BN-12345
Qty Dispensed 500 g
Dispensed On 17/06/2025
Container No. 1 of 2
Initials RK

Annexure-2: Labeling Verification Log

Date Material Batch No. Label Checked By Remarks
17/06/2025 Sodium Chloride BN-12345 Sunita Reddy OK

Annexure-3: Label Control Log

Date Label Type Qty Issued Qty Used Qty Destroyed Verified By
17/06/2025 Dispensed Material Label 10 8 2 QA Executive

Revision History

Revision Date Revision No. Details Reason Approved By
15/02/2022 1.0 Initial issue New SOP QA Head
17/06/2025 2.0 Format updates and label log added Annual Review QA Head
See also  Sterile Injectable Manufacturing: SOP for Batch Release of Injectable Products - V 2.0
Injectables V 2.0 Tags:Aseptic processing SOP, Aseptic technique in sterile manufacturing, Cleanroom SOP for injectables, SOP for ampoule sealing, SOP for autoclave sterilization, SOP for container closure integrity testing, SOP for environmental monitoring in aseptic area, SOP for gowning in cleanroom, SOP for in-process checks in sterile manufacturing, SOP for injectable formulation, SOP for lyophilizer operation, SOP for sterile filtration, SOP for sterilization validation, SOP for vial filling, SOP for visual inspection of injectables, Sterile area cleaning SOP, Sterile filling line SOP, Sterile injectable quality control SOP, Sterile injection SOP, Sterile manufacturing procedure

Post navigation

Previous Post: API Manufacturing: SOP for Control Sample Storage and Testing – V 2.0
Next Post: BA-BE Studies: SOP for System Suitability Test Before Bioanalysis – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2026 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version